CLINICAL_TRIALS trial_result · 2019-10-02

Clinical Trial Update: A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity [Phase 2]

This Phase 2 dose-finding study in Japanese patients with obesity evaluated weight change after treatment with LIK066; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2019-10-02